---
title: "Reckitt self-care chief says AI boosts access to health information, strengthens consumer trust"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293745475.md"
description: "Reckitt's Self-Care chief highlights AI's role in enhancing health information access and consumer trust. The company positions self-care as a key healthcare pillar, focusing on prevention and symptom-led OTC demand. Strategy emphasizes consumer obsession, innovation, and end-to-end journey optimization across digital and physical channels. AI is leveraged for personalized, science-based guidance to build trust without replacing human decision-making, exemplified by campaigns for Gaviscon and Mucinex."
datetime: "2026-07-24T11:00:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293745475.md)
  - [en](https://longbridge.com/en/news/293745475.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293745475.md)
generator: "portal-rs"
---

# Reckitt self-care chief says AI boosts access to health information, strengthens consumer trust

-   Reckitt management flagged self-care as a growing pillar of healthcare as consumers shift toward prevention, monitoring, informed daily decisions. \* SVP Self Care Serra Bicak positioned OTC demand as symptom-led, citing a strategic push to build trust through clearer, science-based guidance. \* Strategy framed around consumer obsession, innovation, execution; focus on end-to-end journeys across search, pharmacies, e-commerce, social platforms. \* AI seen as a key channel for health information discovery; emphasis on personalization, simplification, trust rather than replacing human decision-making. \* Examples cited included Gaviscon “7 Symptoms” education campaign, Mucinex Kickstart positioned for faster morning relief to expand usage occasions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Reckitt Benckiser Group plc published the original content used to generate this news brief on July 24, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [RBGLY.US](https://longbridge.com/en/quote/RBGLY.US.md)
- [RKT.UK](https://longbridge.com/en/quote/RKT.UK.md)
- [RBGLD.US](https://longbridge.com/en/quote/RBGLD.US.md)

## Related News & Research

- [Reckitt posts transcript from Barclays conference fireside chat in Boston](https://longbridge.com/en/news/298481963.md)
- [Reckitt shares rise after US jury backs unit Mead Johnson in baby formula case](https://longbridge.com/en/news/297621527.md)
- [IBEX: Record revenue, strong AI-driven growth, and positive FY27 outlook with robust cash flow](https://longbridge.com/en/news/298639271.md)
- [STX: HAMR technology and AI-driven demand are driving strong exabyte growth and margin expansion](https://longbridge.com/en/news/298632678.md)
- [Morgan Stanley breaks down the midterm races it's watching with implications for AI and the data center boom](https://longbridge.com/en/news/298129524.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**